|
|
|
|
Vol. 60, Issue 6, 1308-1324, December 2001
1-Adrenergic Receptor Transcripts: Role of Potential
Post-Transcriptional Degradation Factors
Division of Neuroscience, Oregon Regional Primate Research Center,
Oregon Health & Science University West Campus, Beaverton, Oregon
(P.K., Y.B., Y.-F.Y., X.L., B.L., C.A.M.); Department of Molecular
Genetics and Microbiology, Robert Wood Johnson Medical School,
University of Medicine and Dentistry of New Jersey, Piscataway, New
Jersey (G.B.); Department of Biochemistry and Molecular Biology and
Graduate Program in Neuroscience, Oregon Health & Science University,
Portland, Oregon (C.A.M.)
The human
1-adrenergic receptor (AR) and hamster
2-AR transcripts can be post-transcriptionally regulated
at the level of mRNA stability and undergo accelerated agonist-mediated
degradation via interaction of their 3' untranslated regions
(UTR) with RNA binding proteins. Using RNase protection assays, we have
determined that chronic isoproterenol exposure of rat C6 glioma cells
results in the accelerated reduction of
1-AR mRNAs. To
determine the role of cellular environment on the agonist-independent
and agonist-mediated degradation of
1-AR mRNAs, we
transfected rat
1-AR expression recombinants into both
hamster DDT1MF2 cells and rat L6 cells. The rat
1-AR mRNAs in the two transfectant cell pools retain longer agonist-independent half-lives than in the C6 environment and
undergo accelerated degradation upon chronic agonist exposure. Using UV-cross-linking/immunoblot and immunoprecipitation analyses, we
have determined that the rat
1-AR 3' UTR recognizes a
predominant Mr 39,000 component, identified
as the mammalian elav-like protein HuR, and several other minor
components, including the heteronuclear protein hnRNP A1. HuR levels
are more highly expressed in C6 cells than in DDT1MF2 and
L6 cells and are induced after chronic isoproterenol treatment.
Furthermore, C6 transfectants containing an HuR expression recombinant
exhibit reduced
1-AR mRNA half-lives that were
statistically comparable with half-lives identified in
isoproterenol-treated C6 cells. These results imply that HuR plays a
potential role in the agonist-independent and agonist-mediated
down-regulation of
1-AR mRNAs.
This article has been cited by other articles:
![]() |
J. Cherry, H. Jones, V. A. Karschner, and P. H. Pekala Post-transcriptional Control of CCAAT/Enhancer-binding Protein {beta} (C/EBP{beta}) Expression: FORMATION OF A NUCLEAR HuR-C/EBP{beta} mRNA COMPLEX DETERMINES THE AMOUNT OF MESSAGE REACHING THE CYTOSOL J. Biol. Chem., November 7, 2008; 283(45): 30812 - 30820. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pullmann Jr., M. Juhaszova, I. L. de Silanes, T. Kawai, K. Mazan-Mamczarz, M. K. Halushka, and M. Gorospe Enhanced Proliferation of Cultured Human Vascular Smooth Muscle Cells Linked to Increased Function of RNA-binding Protein HuR J. Biol. Chem., June 17, 2005; 280(24): 22819 - 22826. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kandasamy, K. Joseph, K. Subramaniam, J. R. Raymond, and B. G. Tholanikunnel Translational Control of {beta}2-Adrenergic Receptor mRNA by T-cell-restricted Intracellular Antigen-related Protein J. Biol. Chem., January 21, 2005; 280(3): 1931 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Gardner, N. M. D. Santos, S. G. Matta, M. A. Whitt, and S. W. Bahouth Role of the Cyclic AMP-dependent Protein Kinase in Homologous Resensitization of the {beta}1-Adrenergic Receptor J. Biol. Chem., May 14, 2004; 279(20): 21135 - 21143. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Michelotti, M. J. Bauman, M. P. Smith, and D. A. Schwinn Cloning and Characterization of the Rat alpha 1a-Adrenergic Receptor Gene Promoter. DEMONSTRATION OF CELL SPECIFICITY AND REGULATION BY HYPOXIA J. Biol. Chem., February 28, 2003; 278(10): 8693 - 8705. [Abstract] [Full Text] [PDF] |
||||